Gut microbiota and inflammation in chronic kidney disease patients

Inflammation is a multifactorial phenotype that in chronic kidney disease is associated with adverse patient outcomes. Recently, alterations in gut microbiota composition and intestinal barrier have been associated with inflammation and oxidative stress in CKD patients. Vanholder and Glorieux recently critically reviewed [Clin Kidney J (2015) 8 (2): 168-179] the current understanding of the role of gut microbiota in the production of uraemic toxins and the therapeutic implications. Where do we stand now? The basic mechanisms of the gut-kidney crosstalk must still be clarified. In addition, the efficacy and safety of therapeutic strategies to modulate the gut microbiota in order to decrease uraemic toxin production and inflammation in chronic kidney disease should be evaluated. Finally, an impact of such strategies on hard outcomes should be demonstrated before incorporation into routine clinical practice.

• Publication year

  2015

• Venue

  Clinical Kidney Journal

• Publication date

  2015-05-06

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/ckj/sfv026PMID 26034597PMCID 4440473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?

  2015cited by this paper
• The intestine and the kidneys: a bad marriage can be hazardous

  2015cited by this paper
• The paratransgenic potential of Lactobacillus kunkeei in the honey bee Apis mellifera.

  2015cited by this paper
• The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.

  2014cited by this paper
• Gut Bacterial Translocation May Aggravate Microinflammation in Hemodialysis Patients

  2014cited by this paper
• High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease

  2014cited by this paper
• Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD

  2014cited by this paper
• Richness of human gut microbiome correlates with metabolic markers

  2013cited by this paper
• Protein-bound uremic toxins…new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease.

  2013cited by this paper
• Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.

  2013cited by this paper
• p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis

  2013cited by this paper
• Chronic kidney disease alters intestinal microbial flora.

  2013cited by this paper
• Indoxyl sulfate induces nephrovascular senescence.

  2012cited by this paper
• CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity

  2012cited by this paper
• Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease.

  2012cited by this paper
• Safety of Probiotics to Reduce Risk and Prevent or Treat Disease

  2011cited by this paper
• Real-Time PCR Analysis of the Intestinal Microbiotas in Peritoneal Dialysis Patients

  2011cited by this paper
• Safety of probiotics used to reduce risk and prevent or treat disease.

  2011cited by this paper
• p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.

  2010cited by this paper
• Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

  2010cited by this paper
• The endocannabinoid system links gut microbiota to adipogenesis

  2010cited by this paper
• Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

  2010cited by this paper
• Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

  2010cited by this paper
• Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.

  1996cited by this paper

• A cross-sectional study on gut microbiota and inflammation in patients with chronic kidney disease.

  2025cites this paper
• Hidden risk of microplastics in milk tea and coffee: A case study from China's freshly-made beverage market.

  2025cites this paper
• Study on the association between microplastic exposure and gut microbiota based on metagenomics: A pilot study on 66 young college students in China.

  2025cites this paper
• Is the enteric nervous system a lost piece of the gut-kidney axis puzzle linked to chronic kidney disease?

  2024cites this paper
• The relationship between dietary fiber, microbiota and kidney diseases in cats and dogs

  2024cites this paper
• The Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases

  2024cites this paper
• Unraveling the Puzzle: Health Benefits of Probiotics—A Comprehensive Review

  2024cites this paper
• Unlocking the Potential of Brewers' Spent Grain: A Sustainable Model to Use Beer for Better Outcome in Chronic Kidney Disease.

  2024cites this paper
• Potential Effects of Bioactive Compounds of Plant-Based Foods and Medicinal Plants in Chronic Kidney Disease and Dialysis: A Systematic Review

  2024influential citation
• Association between dietary fiber intake and cardiovascular mortality in patients with and without chronic kidney disease

  2024cites this paper
• Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know?

  2023cites this paper
• Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases

  2023cites this paper
• Effects of polydextrose supplementation on intestinal function in hemodialysis patients: A double-blind, randomized, placebo-controlled trial.

  2023cites this paper
• Intestinal Lymphatic Dysfunction in Kidney Disease

  2023cites this paper
• The modulation effects of plant‐derived bioactive ingredients on chronic kidney disease: Focus on the gut–kidney axis

  2023cites this paper
• Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021

  2022cites this paper
• Microbiota in health and diseases

  2022cites this paper
• Effects of Resistant Starch on Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Impact of Intestinal Microbiota on Quality of Life (QoL) of Hemodialysis Patients

  2021cites this paper
• Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study

  2021cites this paper
• Association of diabetes and microbiota: An update

  2021cites this paper
• Potential roles of functional bacterial amyloid proteins, bacterial biosurfactants and other putative gut microbiota products in the etiopathogeny of Parkinson’s Disease

  2021cites this paper
• From the distinctive smell to therapeutic effects: Garlic for cardiovascular, hepatic, gut, diabetes and chronic kidney disease.

  2021cites this paper
• Prebiotic Impacts of Soybean Residue (Okara) on Eubiosis/Dysbiosis Condition of the Gut and the Possible Effects on Liver and Kidney Functions

  2021cites this paper
• Effect of cranberry supplementation on toxins produced by the gut microbiota in chronic kidney disease patients: A pilot randomized placebo-controlled trial.

  2021cites this paper
• Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study

  2020cites this paper
• Influence of Mediterranean Diet on Human Gut Microbiota

  2020cites this paper
• Engineering probiotics as living diagnostics and therapeutics for improving human health

  2020cites this paper
• Resistant starch type-2 enriched cookies modulate uremic toxins and inflammation in hemodialysis patients: a randomized, double-blind, crossover and placebo-controlled trial.

  2020cites this paper
• Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study.

  2020cites this paper
• Muscle mass assessment in renal disease: the role of imaging techniques.

  2020cites this paper
• Can nutritional interventions modulate the activation of the NLRP3 inflammasome in chronic kidney disease?

  2020cites this paper
• Hemodialysis—Nutritional Flaws in Diagnosis and Prescriptions. Could Amino Acid Losses Be the Sharpest “Sword of Damocles”?

  2020cites this paper
• Sarcopenia in chronic kidney disease: what have we learned so far?

  2020cites this paper
• Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease.

  2020cites this paper
• To bee or not to bee? The bee extract propolis as a bioactive compound in the burden of lifestyle diseases.

  2020cites this paper
• Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis

  2020cites this paper
• Effects of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in patients on hemodialysis: A double-blind, placebo-controlled, randomized clinical trial.

  2019cites this paper
• Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.

  2019cites this paper
• A possible link between polyunsaturated fatty acids and uremic toxins from the gut microbiota in hemodialysis patients: A hypothesis

  2019cites this paper
• The Gut Microbiome in Chronic Kidney Disease

  2019cites this paper
• Nutrition in chronic kidney disease: Nephrology Dialysis Transplantation notable advances in 2018.

  2019cites this paper
• Dietary Fiber and Gut Microbiota in Renal Diets

  2019cites this paper
• Lyso-Gb3 modulates the gut microbiota and decreases butyrate production

  2019cites this paper
• Quantitative reduction of short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease.

  2019cites this paper
• Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation

  2019cites this paper
• Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies

  2019cites this paper
• Nutritional challenges in malnutrition, inflammation, and atherosclerosis (MIA)syndrome

  2019cites this paper
• Metabolomics of Body Fluids

  2018cites this paper
• The effects of probiotics on renal function and uremic toxins in patients with chronic kidney disease; a meta-analysis of randomized controlled trials

  2018cites this paper
• Intestinal microbiota changes after solid organ transplantation: a systematic review

  2018cites this paper
• Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease

  2018cites this paper
• Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.

  2018cites this paper
• Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis

  2018cites this paper
• Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression

  2018cites this paper
• Vegetarian diets and chronic kidney disease

  2018cites this paper
• Effects of Prebiotic Fiber Xylooligosaccharide in Adenine‐Induced Nephropathy in Mice

  2018cites this paper
• Hepatic Drug Metabolism, Uremic Toxins and Bacterial Composition Over Chronic Kidney Disease Progression

  2017cites this paper
• Gut microbiota in chronic kidney disease.

  2017cites this paper
• Inflammation and premature aging in advanced chronic kidney disease.

  2017cites this paper
• ЭНДОТОКСИН И ХРОНИЧЕСКОЕ ВОСПАЛЕНИЕ ПРИ ХРОНИЧЕСКОЙ ENDOTOXIN AND CHRONIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  2017cites this paper
• Title : Inflammation and premature aging in advanced chronic kidney disease 1

  2017cites this paper
• Gut microbiota in chronic kidney disease.

  2017cites this paper
• Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease

  2017cites this paper
• Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease.

  2016cites this paper
• The Gut Microbiome in the NOD Mouse.

  2016cites this paper
• Could physical exercise help modulate the gut microbiota in chronic kidney disease?

  2016cites this paper
• Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.

  2016cites this paper
• Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?

  2016cites this paper
• Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis

  2016cites this paper
• Macrophages Are Involved in Gut Bacterial Translocation and Reversed by Lactobacillus in Experimental Uremia

  2016cites this paper
• Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.

  2016cites this paper
• Value of Neutrophil Counts in Predicting Surgery-Related Acute Kidney Injury and the Interaction of These Counts With Diabetes in Chronic Kidney Disease Patients With Hypertension

  2015cites this paper
• Genetic diversity of lactic acid bacteria strains towards their potential probiotic application

  2015cites this paper
• Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.

  2013cites this paper
• Perioperative Management of Renal Failure and Renal Transplant

  year unknowncites this paper